title: Comparison of transplanted islets in patients with functioning versus nonfunctioning allografts.
authors.affiliation: Department of Surgery, Washington University School of Medicine, St Louis, Missouri 63110, USA.
authors.forename: C J
authors.initials: CJ
authors.lastname: Swanson
authors.forename: B J
authors.initials: BJ
authors.lastname: Olack
authors.forename: K S
authors.initials: KS
authors.lastname: Flavin
authors.forename: T
authors.initials: T
authors.lastname: Mohanakumar
authors.forename: D C
authors.initials: DC
authors.lastname: Brennan
authors.forename: N H
authors.initials: NH
authors.lastname: White
authors.forename: P E
authors.initials: PE
authors.lastname: Lacy
authors.forename: D W
authors.initials: DW
authors.lastname: Scharp
mesh_terms: D002096:C-Peptide / Q000097:blood; D002469:Cell Separation; D003922:Diabetes Mellitus, Type 1 / Q000097:blood / Q000601:surgery*; D003928:Diabetic Nephropathies / Q000601:surgery; D004359:Drug Therapy, Combination; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007515:Islets of Langerhans / Q000166:cytology; D016381:Islets of Langerhans Transplantation / Q000502:physiology*; D007676:Kidney Failure, Chronic / Q000601:surgery; D016030:Kidney Transplantation; D012189:Retrospective Studies; D013997:Time Factors; D014184:Transplantation, Homologous; D017211:Treatment Failure; D016896:Treatment Outcome
chemical_list: D002096:C-Peptide; D007166:Immunosuppressive Agents